These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34004207)

  • 1. Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity.
    Al-Kuraishy HM; Al-Gareeb AI; Almulaiky YQ; Cruz-Martins N; El-Saber Batiha G
    Eur J Pharmacol; 2021 Aug; 904():174196. PubMed ID: 34004207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast and Coronavirus Disease 2019: A Scoping Review.
    Sharifinejad N; Sharafian S; Salekmoghadam S; Tavakol M; Qorbani M
    Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):384-393. PubMed ID: 34418892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
    Almerie MQ; Kerrigan DD
    Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible Therapeutic Potential of Cysteinyl Leukotriene Receptor Antagonist Montelukast in Treatment of SARS-CoV-2-Induced COVID-19.
    Dey M; Singh RK
    Pharmacology; 2021; 106(9-10):469-476. PubMed ID: 34350893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast as a potential treatment for COVID-19.
    McCarthy MW
    Expert Opin Pharmacother; 2023 Apr; 24(5):551-555. PubMed ID: 36927284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms.
    Sanghai N; Tranmer GK
    Drug Discov Today; 2020 Dec; 25(12):2076-2079. PubMed ID: 32949526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies.
    Marschallinger J; Altendorfer B; Rockenstein E; Holztrattner M; Garnweidner-Raith J; Pillichshammer N; Leister I; Hutter-Paier B; Strempfl K; Unger MS; Chishty M; Felder T; Johnson M; Attems J; Masliah E; Aigner L
    Neurotherapeutics; 2020 Jul; 17(3):1061-1074. PubMed ID: 32072462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Copertino DC; Duarte RRR; Powell TR; de Mulder Rougvie M; Nixon DF
    J Med Virol; 2021 Jan; 93(1):187-189. PubMed ID: 32658304
    [No Abstract]   [Full Text] [Related]  

  • 9. Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model.
    Han B; Zhang YY; Ye ZQ; Xiao Y; Rasouli J; Wu WC; Ye SM; Guo XY; Zhu L; Rostami A; Wang LB; Zhang Y; Li X
    Immunology; 2021 Jun; 163(2):185-200. PubMed ID: 33480040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene receptor antagonism with montelukast as a possible therapeutic for venous thromboembolism prophylaxis: An observational study.
    Sutton SS; Magagnoli J; Cummings TH; Hardin JW
    Prostaglandins Other Lipid Mediat; 2022 Aug; 161():106649. PubMed ID: 35595009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levocetirizine and montelukast in the COVID-19 treatment paradigm.
    May BC; Gallivan KH
    Int Immunopharmacol; 2022 Feb; 103():108412. PubMed ID: 34942461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. As a potential treatment of COVID-19: Montelukast.
    Fidan C; Aydoğdu A
    Med Hypotheses; 2020 Sep; 142():109828. PubMed ID: 32416408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast in hospitalized patients diagnosed with COVID-19.
    Khan AR; Misdary C; Yegya-Raman N; Kim S; Narayanan N; Siddiqui S; Salgame P; Radbel J; Groote F; Michel C; Mehnert J; Hernandez C; Braciale T; Malhotra J; Gentile MA; Jabbour SK
    J Asthma; 2022 Apr; 59(4):780-786. PubMed ID: 33577360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson's Disease.
    Wallin J; Svenningsson P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension.
    Trost A; Motloch K; Koller A; Bruckner D; Runge C; Schroedl F; Bogner B; Kaser-Eichberger A; Strohmaier C; Ladek AM; Preishuber-Pfluegl J; Brunner SM; Aigner L; Reitsamer HA
    Exp Eye Res; 2021 Dec; 213():108806. PubMed ID: 34715090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of respiratory syncytial virus-induced bronchiolitis co-infection with Mycoplasma pneumoniae and add-on therapy with montelukast.
    Wu SH; Chen XQ; Kong X; Yin PL; Dong L; Liao PY; Wu JM
    World J Pediatr; 2016 Feb; 12(1):88-95. PubMed ID: 25846070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory medications for the treatment of pediatric obstructive sleep apnea.
    Kuhle S; Urschitz MS
    Paediatr Respir Rev; 2020 Apr; 34():35-36. PubMed ID: 32245548
    [No Abstract]   [Full Text] [Related]  

  • 18. LTA4H rs2660845 association with montelukast response in early and late-onset asthma.
    Maroteau C; Espuela-Ortiz A; Herrera-Luis E; Srinivasan S; Carr F; Tavendale R; Wilson K; Hernandez-Pacheco N; Chalmers JD; Turner S; Mukhopadhyay S; Maitland-van der Zee AH; Burchard EG; Pino-Yanes M; Young S; Lassi G; Platt A; Palmer CNA;
    PLoS One; 2021; 16(9):e0257396. PubMed ID: 34550981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast in pediatric asthma management.
    Walia M; Lodha R; Kabra SK
    Indian J Pediatr; 2006 Apr; 73(4):275-82. PubMed ID: 16816486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of leukotrienes in inflammation and leukotriene inhibitors].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.